Premium
Serum lipids and hippocampal volume: The link to Alzheimer's disease?
Author(s) -
den Heijer Tom,
Hofman Albert,
Koudstaal Peter J.,
Breteler Monique M. B.
Publication year - 2005
Publication title -
annals of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.764
H-Index - 296
eISSN - 1531-8249
pISSN - 0364-5134
DOI - 10.1002/ana.20469
Subject(s) - erasmus+ , biostatistics , medicine , rotterdam study , epidemiology , neurology , gerontology , psychiatry , history , art history , the renaissance
References 1. Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003;4:873–884. 2. Giuffrida A, Leweke FM, Gerth CW, et al. Cerebrospinal anandamide levels are elevated in acute schizophrenia and are inversely correlated with psychotic symptoms. Neuropsychopharmacology 2004;29:2108–2114. 3. Gubellini P, Picconi B, Bari M, et al. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission. J Neurosci 2002;22:6900–6907. 4. Di Marzo V, Hill MP, Bisogno T, et al. Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson’s disease. FASEB J 2000;14:1432–1438. 5. Hurley MJ, Mash DC, Jenner P. Expression of cannabinoid CB1 receptor mRNA in basal ganglia of normal and parkinsonian human brain. J Neural Transm 2003;110:1279–1288.